![Chi-Feng Chang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chi-Feng Chang
Directeur/Membre du Conseil chez
TANVEX BIOPHARMA, INC.
Profil
Chi-Feng Chang is currently the Chief Executive Officer at Apexcella Biomedical, Inc., an Independent Director at Tanvex BioPharma, Inc., and a Director at Stembios Technologies, Inc. Previously, Dr. Chang served as the Vice President at Pharmigene, Inc. Dr. Chang holds a doctorate degree from The University of Chicago.
Postes actifs de Chi-Feng Chang
| Sociétés | Poste | Début |
|---|---|---|
| TANVEX BIOPHARMA, INC. | Directeur/Membre du Conseil | - |
Stembios Technologies, Inc. | Directeur/Membre du Conseil | - |
Anciens postes connus de Chi-Feng Chang
| Sociétés | Poste | Fin |
|---|---|---|
| PHARMIGENE, INC. | Corporate Officer/Principal | - |
Formation de Chi-Feng Chang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmigene, Inc.
 Pharmigene, Inc. Pharmaceuticals: GenericHealth Technology Provides genetic based diagnostic solutions | Health Technology |
Tanvex BioPharma, Inc.
 Tanvex BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biosimilar medicines to treat neutropenia, breast cancer and metastatic colorectal cancer | Health Technology |
Stembios Technologies, Inc. |
Choisissez Zonebourse 
